These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23789366)

  • 21. Optimal preparation methods for automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling of low molecular weight proteins and peptides.
    Penno MA; Ernst M; Hoffmann P
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2656-62. PubMed ID: 19630030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer biomarker discovery using high performance mass spectral serum profiling.
    Oh JH; Lotan Y; Gurnani P; Rosenblatt KP; Gao J
    Comput Methods Programs Biomed; 2009 Oct; 96(1):33-41. PubMed ID: 19423179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
    Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
    Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
    Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
    Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
    Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
    Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum peptidome profiling in patients with lung cancer.
    Yang J; Yang SY; Hu XY; Huo SF; Shang WL; Li ZF; Ni L; Wang AY; Guo YM; Song TS; Chen-Huang
    Anat Rec (Hoboken); 2010 Dec; 293(12):2027-33. PubMed ID: 21082738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.
    Wang QT; Li YZ; Liang YF; Hu CJ; Zhai YH; Zhao GF; Zhang J; Li N; Ni AP; Chen WM; Xu Y
    Anat Rec (Hoboken); 2009 Apr; 292(4):604-10. PubMed ID: 19301277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of mass spectrometry of urinary proteins and peptides as biomarkers for cats at risk of developing azotemia.
    Jepson RE; Coulton GR; Cowan ML; Markwell P; Syme HM; Elliott J
    Am J Vet Res; 2013 Feb; 74(2):333-42. PubMed ID: 23363362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of serum diagnosis of pancreatic cancer by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Gao H; Zheng Z; Yue Z; Liu F; Zhou L; Zhao X
    Int J Mol Med; 2012 Nov; 30(5):1061-8. PubMed ID: 22941199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Screening and expression of tumor markers in laryngeal carcinoma].
    Xu Y; Wang B; Huangfu H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 25(9):409-12. PubMed ID: 21805835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum.
    Lebrecht A; Boehm D; Schmidt M; Koelbl H; Grus FH
    Cancer Genomics Proteomics; 2009; 6(2):75-83. PubMed ID: 19451091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHASE, a charge-assisted sequencing algorithm for automated homology-based protein identifications with matrix-assisted laser desorption/ionization time-of-flight post-source decay fragmentation data.
    Raucci G; Gabrielli M; Novelli S; Picariello G; Collins SH
    J Mass Spectrom; 2005 Apr; 40(4):475-88. PubMed ID: 15712359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
    Ndao M
    Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS.
    Lei L; Wang XJ; Zheng ZG; Huang J; Cao WM; Chen ZH; Shao XY; Cai JF; Ye WW; Lu HY
    Anat Rec (Hoboken); 2011 Jun; 294(6):941-4. PubMed ID: 21548109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening of serum protein biomarkers by surface-enhanced laser desorption and ionization with time-of-flight detection mass spectrometry in patients with mycosis fungoides].
    Liu J; Zheng YH; Zhang JZ; Wang BX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):13-6. PubMed ID: 19317049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic protein discovery using proteolytic peptide targeting and identification.
    Koomen JM; Zhao H; Li D; Abbruzzese J; Baggerly K; Kobayashi R
    Rapid Commun Mass Spectrom; 2004; 18(21):2537-48. PubMed ID: 15468157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry--plasma peptidomes from nasopharyngeal cancer patients for example.
    Chang JT; Chen LC; Wei SY; Chen YJ; Wang HM; Liao CT; Chen IH; Cheng AJ
    Clin Biochem; 2006 Dec; 39(12):1144-51. PubMed ID: 17014837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.